|
시장보고서
상품코드
2052731
트랜스펙션 시약 및 장비 시장 : 제품별, 방법별, 최종사용자별, 지역별Transfection Reagents and Equipment Market, By Product, By Method, By End User, and By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
트랜스펙션 시약 및 장비 시장은 2026년에 15억 2,520만 달러로 추정되며, 2033년까지 28억 7,890만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.5%로 성장할 것으로 전망됩니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 15억 2,520만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026년부터 2033년까지 예측 기간 CAGR: | 9.50% | 2033년 시장 규모 예측: | 28억 7,890만 달러 |
트랜스펙션은 비바이러스적인 방법을 이용하여 진핵세포에 핵산을 도입하는 과정입니다. 이 절차에 사용되는 시약과 장비를 트랜스펙션 시약 및 장비라고 합니다. 트랜스펙션은 다양한 세포 유형에서 유전자 및 단백질의 발현을 연구하기 위한 강력한 분석 도구가 되고 있습니다.
시장 역학:
만성 질환의 유병률 증가, 트랜스펙션 시약 및 장비에 대한 수요 증가, 새로운 치료법 개발에 대한 관심 증가, 연구개발(R&D) 확대 등이 세계 트랜스펙션 시약 및 장비 시장의 성장을 견인할 것으로 예상됩니다.
예를 들어, 2022년 8월, 바이러스 바이오는 세포 치료제 및 유전자 치료제의 개발 및 공정 활동과 상업적 생산을 지원하기 위해 GMP(Good Manufacturing Practice)를 준수하는 TransIT VirusGen 플랫폼과 바이러스 벡터 제조 사업을 확장했습니다.
또한, 2022년 4월, BOC Sciences는 자사의 인기 제품 시리즈인 in vivo delivery 제품군에 siRNA 및 mRNA의 in vivo transfection에 적합한 siRNA in vivo transfection kit 및 mRNA in vivo 트랜스펙션 키트를 출시하였습니다.
본 조사의 주요 특징:
- 이 보고서는 다양한 부문의 잠재적 수익 창출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 기업의 주요 특징, 제품 포트폴리오, 주요 특징, 재무 실적, 전략 등의 매개 변수를 기반으로 세계 트랜스펙션 시약 및 장비 시장의 주요 기업 프로파일을 작성했습니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 트랜스펙션 시약 및 장비 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 트랜스펙션 시약 및 장비 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 트랜스펙션 시약 및 장비 시장 : 제품별, 2021-2033년
제5장 세계의 트랜스펙션 시약 및 장비 시장 : 방법별, 2021-2033년
제6장 세계의 트랜스펙션 시약 및 장비 시장 : 최종사용자별, 2021-2033년
제7장 세계의 트랜스펙션 시약 및 장비 시장 : 지역별, 2021-2033년
제8장 경쟁 구도
제9장 섹션
KSM 26.06.17Transfection Reagents And Equipment Market is estimated to be valued at USD 1,525.2 Mn in 2026 and is expected to reach USD 2,878.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.5% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1,525.2 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.50% | 2033 Value Projection: | USD 2,878.9 Mn |
Transfection is the process of introducing nucleic acids into eukaryotic cells by non-viral methods. The reagents and equipment used in these procedures are referred to as transfection reagents and equipment. Transfection has become the powerful analytical tool for the study of gene or protein expression in a wide variety of cell types.
Market Dynamics:
Increase in prevalence of chronic diseases, rise in demand for transfection reagents and equipment, increase in focus on the development of novel therapies, and increase in research and development (R&D) is expected to boost growth of the global transfection reagents and equipment market.
For instance, in August 2022, Mirus Bio expanded its TransIT VirusGen platform compliant with good manufacturing practices (GMP) and viral vector manufacturing to support both cell and gene therapy development and process activities and commercial production.
Moreover, in April 2022, BOC Sciences released in-vivo RNA transfection kits in the company's popular in vivo delivery product series, including siRNA in vivo transfection kits and mRNA in vivo transfection kits, suitable for in vivo transfection of siRNA and mRNA, respectively.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global transfection reagents and equipment market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Qiagen NV, Promega Corporation, Polyplus-transfection SA, Mirus Bio LLC, Merck KgaA, MaxCyte Inc., Lonza Group, Bio-Rad Laboratories Inc., and Thermo Fisher Scientific Inc., among others.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global transfection reagents and equipment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global transfection reagents and equipment market.
Detailed Segmentation:
- Global Transfection Reagents and Equipment Market, By Product (Revenue, USD Mn, 2021 - 2033)
- Reagents
- Equipment
- Global Transfection Reagents and Equipment Market, By Method (Revenue, USD Mn, 2021 - 2033)
- Biochemical Methods
- Physical Methods
- Viral Methods
- Global Transfection Reagents and Equipment Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Academics and Research Institutes
- Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles:
- Qiagen NV
- Promega Corporation
- Polyplus-transfection SA
- Mirus Bio LLC
- Merck KgaA
- MaxCyte Inc.
- Lonza Group
- Bio-Rad Laboratories Inc.
- Thermo Fisher Scientific Inc.
Table of Contents:
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Method
- Market Snapshot, By End User
- Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Rise in demand for transfection reagents and equipment
- High cost and certain limitations of transfection reagents
- Increase in demand for synthetic genes worldwide
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global Transfection Reagents and Equipment Market, By Product, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Reagents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Equipment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
5. Global Transfection Reagents and Equipment Market, By Method, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Biochemical Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Physical Method
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Viral Methods
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Global Transfection Reagents and Equipment Market, By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Academics and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
7. Global Transfection Reagents and Equipment Market, By Geography, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Method, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033,(US$ Mn)
- GCC Countries
- Israel
- Rest of Middle East
- South Africa
- North Africa
- Central Africa
8. Competitive Landscape
- Qiagen NV
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Promega Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Polyplus-transfection SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mirus Bio LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KgaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- MaxCyte Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bio-Rad Laboratories Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Analyst Views
9. Section
- Research Methodology
- About us
